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SObjective: Although it is known that preoperative decreased left ventricular ejection fraction (LVEF) is a risk
for morbidity and mortality after cardiac surgery, there are no reliable markers of risk in patients with preserved
LVEF. This study examines whether a prolonged QTc interval is associated with adverse outcomes in patients
with preoperative LVEF greater than 40% undergoing cardiac surgery.
Methods:A retrospective chart reviewof patientswhohad cardiac surgery at St. Paul’sHospital inVancouver, Can-
ada, between 2004 and 2009, who had a preoperative LVEF greater than 40%, was undertaken.We tested for asso-
ciationofpreoperative prolongedQTc intervalwithmortality andmorbidity usingunadjusted and adjusted analyses.
Results: Five-hundred and fifty-five patientswith a preoperativeLVEFgreater than 40%were included in the study;
496 (89.4%) had cardiopulmonary bypass and the remainder were off pump. Preoperative prolongedQTcwas asso-
ciatedwith increasedmortality at 30days (P<.01), 90days (P<.01), and8years (P<.01), and these results remained
significant after adjusting for the clinical variables significantly associated with mortality (8-year odds ratio, 2.42;
95% confidence interval, 1.34-4.34; P ¼ .003). Similar results were found when the analysis was restricted to the
more homogeneous group of patients undergoing on-pump coronary artery bypass (CABG, n ¼ 408). Prolonged
QTc was also associated with prolonged intensive care unit stay (P ¼ .02), prolonged hospital stay (P< .01),
development of atrial arrhythmias (P ¼ .02), and low cardiac output syndrome (on-pump CABG, P ¼ .02).
Conclusions: In patients undergoing cardiac surgery and a preoperative LVEF greater than 40%, a prolonged
QTc interval is associated with increased short-term and long-term mortality and increased perioperative
morbidity, and therefore should be considered when assessing risk preoperatively. (J Thorac Cardiovasc Surg
2014;147:1627-33)GThe heart ratecorrected QT interval (QTc) in the resting
12-lead electrocardiogram (ECG) provides important prog-
nostic information on several conditions. QTc interval
prolongation is associated with increased mortality in
coronary heart disease and with increased ventricular
arrhythmias and sudden cardiac death in diabetic and
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The Journal of Thoracic and Carassociation between prolonged QTc and postoperative
outcomes after cardiac surgery.4-6 In all studies,
prolonged preoperative QTc (>440 milliseconds) was
associated with increased mortality. Vrtovec and
colleagues4 restricted their study to patients who had a
left ventricular ejection fraction (LVEF) less than 40%,
whereas Kinoshita and colleagues5 and Foroughi and
colleagues6 studied patients with any LVEF. Kinoshita
and colleagues5 found that prolonged QTc interval is a
predictor of all-cause mortality and sudden cardiac death
over 5 years of follow-up in patients undergoing off-pump
coronary surgery. However, whether preoperative pro-
longed QTc is associated with early and long-term
postoperative adverse outcomes is unclear in cardiac
surgical patients with an LVEF greater than 40%, who
are typically considered low risk. Our hypothesis was that
prolonged QTc is associated with increased postoperative
morbidity and mortality in patients undergoing cardiac
surgery who have a preoperative LVEF greater than 40%.PATIENTS AND METHODS
Patients
Patients admitted to the cardiac surgical intensive care unit (ICU) at
St. Paul’s Hospital in Vancouver, Canada, between January 2004 and
December 2009 were recruited to the study (n ¼ 834). The primarydiovascular Surgery c Volume 147, Number 5 1627
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
CI ¼ confidence interval
ECG ¼ electrocardiogram
eGFR ¼ estimated glomerular filtration rate
ICU ¼ intensive care unit
LCOS ¼ low cardiac output syndrome
LVEF ¼ left ventricular ejection fraction
OR ¼ odds ratio
QTc ¼ corrected QT interval
STS ¼ Society of Thoracic Surgeons
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Sinclusion criteria were availability of a preoperative ECG within 3 months
of surgery and preoperative LVEF greater than 40% (n ¼ 691). Exclusion
criteria included preoperative atrial fibrillation, a preoperatively implanted
pacemaker, patients who had prolonged QRS duration (120 millisec-
onds), and use of QT-prolonging drugs including amiodarone, procaina-
mide, or antipsychotic drugs; leaving 555 patients for this study. In
British Columbia, there is a single payor government universal health
plan into which all citizens are enrolled while living in the province.
Patients were censored on disenrollment from the health plan if theymoved
outside the province. Provincial vital statistics were used to determine the
date of death. The research ethics boards of participating institutions
approved this study and written informed consent was obtained from all
patients or their authorized representatives. The institutional review board
at St. Paul’s Hospital and the University of British Columbia approved the
study.
Electrocardiographic Measurements
Standard 12-lead resting ECG tracings at 25 mm/s paper speed and
10 mm/mV amplitude were performed before surgery using a MAC-5500
digital ECG system (GE Medical Systems). ECGs were analyzed using a
Marquette 12SL ECG analysis program (GE Medical Systems). Every
hard copy ECG was also reinterpreted by a cardiologist. The QT measure-
ment was made in leads II and V5 or V6, and the longest value was used.
QT interval was corrected for heart rate (QTc) using the Bazett formula.
The QT interval was measured from the beginning of the earliest onset
of the QRS complex to the end of the T wave. The end of the T wave
was defined as the return of the descending limb to the isoelectric line.
When a discrete U wave was present after the T wave, the T wave offset
was defined as the nadir between the T and U waves. When the T and
U waves were fused, the U component was calculated as the T wave.
Prolonged QTcwas defined by using gender-specific QT categories (males,
QTc  450 milliseconds; females, QTc  470 milliseconds).
Primary and Secondary Outcomes
The primary outcome variables were 30-day, 90-day, and 8-year
mortality. The secondary outcome variables measured during the
perioperative hospitalization were prolonged ICU stay defined as a stay
in the cardiac ICU more than 48 hours,7 prolonged hospital stay defined
as greater than 14 days,8 development of atrial arrhythmias, and
development of low cardiac output syndrome (LCOS).
New-onset postoperative atrial arrhythmias were defined as any episode
of atrial fibrillation or flutter within 30 days after surgery that required
treatment. LCOS was diagnosed if (1) patients required an intra-aortic
balloon pump to be weaned from cardiopulmonary bypass or in the ICU
because of hemodynamic compromise, or (2) the patient required inotropic
drug(s) to maintain systolic blood pressure greater than 90 mm Hg and
cardiac index greater than 2.2 L/min/m2 for at least 30 minutes in the1628 The Journal of Thoracic and Cardiovascular SurICU and excluding patients who received less than 4 mg/kg of dopamine
to increase renal perfusion or patients who received vasoconstrictor drugs
to increase systemic vascular resistance.9,10
Baseline and Perioperative Measurements
Baseline characteristics of the patients were measured at study
enrollment including age, gender, preexisting conditions (hypertension,
diabetes, and myocardial ischemia, based on patients’ recorded past
medical history), current medications, LVEF, electrolytes, serum
creatinine, and an estimated glomerular filtration rate (eGFR) using the
Modification of Diet in Renal Disease Study equation. The impaired renal
function was defined as eGFR less than 60m//min/1.73m2.11 The operative
variables recorded were whether or not on cardiopulmonary bypass pump,
cardiopulmonary bypass times, aortic crossclamp times, the cardioplegia
temperature, type of cardioplegia, and urgency of operation (urgent
indicating an operation within 48 hours). New-onset postoperative atrial
arrhythmias were recorded if patients had atrial arrhythmias from a
12-lead ECG in the hospital computer system.
Statistical Analysis
Statistical analysis was performed using R, version 2.8.1 (www.R-
project.org) and SPSS, version 16 (SPSS, Inc; Chicago, Ill) statistical
software packages. Patients who had prolonged QTc were compared
with patients with normal QTc and tested for differences in baseline
characteristics and adverse outcomes using the Mann-Whitney U statistic
test for continuous data or a chi-squared test for categorical data. Normally
distributed continuous variables were summarized by mean and standard
deviation, whereas nonnormally distributed continuous variables were
summarized by median and interquartile ranges. Categorical variables
were expressed as the number of patients and percentage. The Pearson
correlation coefficient was calculated for the relationship (continuous)
between the QTc interval and continuous variables of baseline and adverse
outcome data. Logistic regression was used to measure the association
between the clinical variables and mortality. Risk factors determined to
be clinically significant a priori on the bivariable analyses were identified
as candidate variables for the multivariable model. Survival analysis was
compared between 2 groups using the log-rank test. Cox regression
analysis was used to test for differences in survival and included those
baseline variables from the univariate analysis with P< .05. In view of
the heterogeneity of this cardiac surgery cohort, the analysis was repeated
in the largest subset of patients; those undergoing coronary artery bypass
surgery using cardiopulmonary bypass. Observed and predicted mortality
risk were compared using Society of Thoracic Surgeons (STS) risk scores
(version 2.73).12 In all comparisons, P<.05 was considered statistically
significant.RESULTS
Baseline Characteristics
Of 555 patients who had a preoperative LVEF greater
than 40% and underwent cardiac surgery, 496 (89.4%)
had cardiopulmonary bypass; 465 (83.8%) underwent
cardiopulmonary bypass with coronary artery bypass graft
surgery (CABG), 14 (2.5%) patients underwent valve
surgery, 66 (11.9%) patients underwent combined valve
plus CABG, and 10 (1.8%) patients underwent other
cardiac surgery. The preoperative QTc interval was
normally distributed. The mean of the preoperative QTc
interval was 427  35 milliseconds, preoperative LVEF
was 55  8%, and the mean age was 67  10 years.
Eighty-four (15.1%) patients had a prolonged QTc intervalgery c May 2014
TABLE 1. Baseline characteristics of patients who had cardiac




QTc (n ¼ 471)
Prolonged
QTc (n ¼ 84) P
Age, y 67 (59-73) 72 (63-79) <.01*
Race: white, n (%) 429 (91.1) 80 (95.2) .28
Gender: male, n (%) 380 (80.7) 71 (84.5) .45
Body mass index, kg/m2 27.5 (25-31) 27 (25-31) .76
Preoperative LVEF,% 57 (50-60) 50 (45-60) <.01*
Preoperative QTc interval,
milliseconds
416 (402-432) 480 (463-500) <.01*
Preoperative Na, mmol/L 140 (138-141) 140 (137-141) .86
Preoperative K,
mean mmol/L  SD
4.22 ( 0.45) 4.17 ( 0.43) .58
Preoperative Mg,
mean mmol/L  SD
1.06 ( 0.25) 1.00 ( 0.10) .50
Preexisting condition, n (%)
Hypertension 370 (78.6) 70 (83.3) .38
Smoker 67 (14.2) 12 (14.3) 1.00
Diabetes mellitus 128 (27.2) 28 (33.3) .29
Dyslipidemia 366 (77.7) 67 (79.8) .77
Impaired renal function 79 (16.8) 31 (36.9) <.01*
End-stage renal disease 8 (1.7) 2 (2.4) .66
Congestive heart failure 365 (77.5) 66 (78.6) .83
History of MI 56 (11.9) 14 (16.7) .29
Medications, n (%)
Aspirin 395 (83.9) 72 (85.7) .75
Clopidogrel 62 (13.2) 9 (10.7) .60
ACE inhibitor 182 (38.6) 32 (38.1) 1.00
b-Blocker 324 (68.8) 48 (57.1) .04*
Calcium blocker 122 (25.9) 21 (25.0) 1.00
Statin 309 (65.6) 46 (54.8) .06
Perioperative data, n (%)
Urgent operation 65 (13.8) 15 (17.8) .32
On CPB pump 419 (88.9) 77 (91.7) .57
Bypass time, min 83 (63-101) 87 (62-110) .29
Aortic crossclamp time, min 64 (42-81) 65 (41-87) .62
Data are median (interquartile range) for continuous variables. QTc, Corrected
QT interval; LVEF, left ventricular ejection fraction; SD, standard deviation;
MI, myocardial ischemia; CPB, cardiopulmonary bypass. *P<.05.
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and 10.8% at 8 years after surgery. Prolonged ICU stay
occurred in 13.3%, prolonged hospital stay occurred in
8.5%, new-onset atrial arrhythmias developed in 7.7%
with a median time to onset of 3.5 days (range, 0 to 18
days) and LCOS developed in 21.1%; the cardioplegia
temperature, type of cardioplegia, and cardiopulmonary
bypass were not statistically significantly associated with
patients who had developed LCOS. Three patients required
the intra-aortic balloon pump after surgery. Patients who
had a prolonged QTc were significantly older (72 vs 67
years, P< .01) and had a lower LVEF (50% vs 57%,
P < .01) than patients who had a normal QTc. There
were no other significant differences between the groups
(Table 1).
Primary Outcome
Kaplan-Meier survival curves (Figure 1) demonstrated
that patients with a prolonged QTc interval had significantly
higher 30-day, 90-day, and 8-year mortality than patients
with a normal QTc interval (P < .05). Cox regression
analysis to adjust for the clinical variables significantly
associated with mortality outcome (age, LVEF, prolonged
QTc, urgent operation, impaired renal function, and type
of operation) confirmed that patients with prolonged QTc
had higher mortality (30-day odds ratio [OR], 9.09; 95%
confidence interval [CI], 1.54-53.61; P ¼ .015; 90-day
OR, 7.69; 95% CI, 2.41-24.55; P ¼ .001; 8-year OR,
2.42; 95% CI, 1.34-4.34; P ¼ .003) than patients with
normal QTc. To determine whether there was an increase
in mortality as QTc increased to more than 400 millisec-
onds, we compared patients in the following subgroups:
less than 400, 401-420, 421-440, 441-460, 461-480,
481-500, and more than 500 milliseconds. Figure 2 shows
that, although all levels of prolonged QTc were associated
with increased mortality, there was a marked increase in
mortality from less than 5% to greater than 25% as QTc
increased.
Secondary Outcomes
Patients with a prolonged QTc also had significantly
increased incidences of prolonged ICU stay (P ¼ .02) and
hospital stay (P < .01) (Table 2). Multiple logistic
regression analysis to adjust for the clinical variables
significantly associated with mortality (age, LVEF,
prolonged QTc, urgent operation, impaired renal function,
and type of operation) confirmed that patients with pro-
longed QTc had a trend toward more frequent prolonged
ICU stay (OR, 1.59; 95% CI, 0.91-3.06; P ¼ .092) and
had more frequent prolonged hospital stay (OR, 2.36;
95% CI, 1.16-4.78; P ¼ .018). Patients who had prolonged
QTc interval had significantly more atrial arrhythmias than
patients with normal QTc (13.1% vs 6.8%, P ¼ .04;
Table 2). To determine whether there was an increase inThe Journal of Thoracic and Carthe incidence of atrial arrhythmias as QTc increased to
more than 400 milliseconds, we compared patients in
the following subgroups: QTc less than 400, 401-420,
421-440, 441-460, 461-480, 481-500 and more than 500
milliseconds. Risk of atrial arrhythmia increased with any
prolongation of QTc but a much higher risk was observed
with QTc greater than 500 milliseconds (Figure 2). Patients
with a prolonged QTc also had a trend toward increased
incidence of perioperative LCOS (Table 2).
Increased mortality in patients with a prolonged QTc was
not accounted for by the increase in atrial arrhythmias in
these patients. Table 3 shows that patients with preoperative
prolonged QTc who did not develop atrial arrhythmias still
had an 11-fold, 6-fold, and 3-fold increase in risk of 30-day,
90-day, and 8-year mortality, respectively, compared withdiovascular Surgery c Volume 147, Number 5 1629
FIGURE 1. Kaplan-Meier survival curves for patients who underwent cardiac surgery and who had a left ventricular ejection fraction greater than 40%.
QTc, Corrected QT interval.
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patients who had prolonged QTc who did not develop atrial
arrhythmias had more frequent prolonged ICU stay
(P ¼ .039) and hospital stay (P<.01) than patients with a
normal QTc interval (Table 3).
Homogeneous Subgroup
The overall cohort of patients included the following
procedures: on-pump and off-pump CABG, valve,
combined valve and CABG, and other surgery. To confirm
that our observations were not due to this mixture, we
repeated the analysis for the largest homogenous group of
patients, that is, patients who underwent on-pump CABG
(n ¼ 408). Baseline characteristics of on-pump CABG1630 The Journal of Thoracic and Cardiovascular Surpatients were similar to all patients. In this large, more ho-
mogeneous subgroup, patients with preoperative prolonged
QTc had increased mortality at 30 days, 90 days, and 8 years
(Table 2). These patients also had an increased incidence of
prolonged hospital stay (Table 2). In addition, patients with
prolonged QTc developed more atrial arrhythmias (P¼ .04,
Table 2) and had a higher incidence of LCOS (P ¼ .02,
Table 2) compared with patients who had normal QTc. We
compared observed and STS predicted mortality risk in
on-pump CABG patients. The observed and predicted STS
mortalities matched for those patients with a normal QTc
interval (0.8 vs 0.5). However, the observed mortality
greatly exceeded the predicted STS risk model in patients
who had preoperative prolongedQTc interval (7.27 vs 0.76).gery c May 2014
FIGURE 2. Incidence of 90-day mortality and new-onset postoperative
atrial fibrillation (AF) according to the preoperative QTc interval of
patients who had cardiac surgery and who had a left ventricular ejection
fraction greater than 40%. QTc, Corrected QT interval.




The major finding of this study is that in patients who
have cardiac surgery and a preoperative LVEF greater
than 40% (generally considered low risk), prolonged QTc
measured preoperatively is a risk for significantly increased
30-day, 90-day, and 8-year mortality and increased
perioperative complications of atrial arrhythmia and
LCOS. These findings remained in a repeat analysis of a
more homogeneous subset; patients who underwent
on-pump cardiopulmonary bypass with coronary artery
graft surgery. Although previous studies have analyzed
the risks associated with prolonged QTc interval after
cardiac surgery; definitions of prolonged QTc varied4,6
and patients were restricted to those with heart failure
(ie, decreased LVEF)4 or those who underwent off-pump
surgery.5 By focusing on patients with LVEF greater than
40%, we selected patients generally deemed to be low
risk yet still found highly significant adverse mortalityThe Journal of Thoracic and Carand morbidity outcomes associated with prolonged
QTc. This adds to knowledge from previous studies
demonstrating that prolonged QTc is an important risk
factor.4-6,13
Modern surgical techniques and reduced cardiopulmo-
nary bypass times have resulted in excellent outcomes for
cardiac surgeries including CABG and valvular surgeries.
Nonetheless, there remains a 1% to 2% risk of death
even among patients without recognized risk factors such
as end-stage renal failure, advanced heart failure, or older
age.14,15 It is important to identify patients who have
increased risk not only in the interest of their informed
consent but also to tailor management such as duration of
high acuity monitoring and care as well as pharmacologic
therapy for prevention of arrhythmias. The preoperative
ECG is inexpensive and in this study, we found that it was
of significant usefulness in predicting which otherwise
low-risk patients (with LVEF greater than 40%) were at
increased risk of death, postoperative atrial arrhythmias,
and LCOS.
The QTc interval reflects the cardiac depolarization and
repolarization times in 1 heart cycle16 and, in population
surveys, prolonged QTc interval is associated with an
increased risk of atrial-ventricular arrhythmias and ventric-
ular systolic and diastolic dysfunction.17,18 Previous studies
have shown an association between prolonged QTc and
adverse postoperative outcomes including increased
mortality.4-6 However, this association could have been
confounded by the common coexistence of prolonged
QTc with depressed left ventricular function as expressed
by decreased LVEF. So it has not been clear whether
prolonged QTc is an independent predictor of adverse
outcomes after cardiac surgery. The STS risk model was
developed to estimate the risk of operative mortality,
based on multiple risk factors, to guide surgeons and
cardiologists caring for patients undergoing isolated
CABG, valve replacement, and CABG plus valve
replacement. However, preoperative QTc interval is not
one of preoperative variables in the STS risk model.
Several studies have shown that observed mortality can be
significantly higher than predicted STS mortality in the
setting of other comorbidities.19,20 Our results add to this
knowledge by finding that predicted STS mortality risk
underestimates mortality in patients with preoperative
prolonged QTc interval. Thus, risk assessment should
additionally consider QTc when planning perioperative
management.
Our study is novel for several reasons. First, we found
an association between prolonged QTc and increased
short-term and long-term mortality in patients undergoing
cardiac surgery who had an LVEF greater than 40%.
Second, we found that prolonged QTc was associated
with increased incidence of prolonged hospital stay,
increased risk of postoperative atrial arrhythmias, anddiovascular Surgery c Volume 147, Number 5 1631
TABLE 2. Postoperative outcomes of patients who had cardiac surgery and who had a left ventricular ejection fraction greater than 40% (all
patients, n ¼ 555) and largest homogeneous group; on-pump CABG (n ¼ 408)
Outcome
All patients (n ¼ 555) On-pump CABG (n ¼ 408)
Normal QTc (n ¼ 471) Prolonged QTc (n ¼ 84) P Normal QTc (n ¼ 353) Prolonged QTc (n ¼ 55) P
30-d mortality, n (%) 3 (0.6) 5 (6) <.01* 1 (0.3) 2 (3.6) .05
90-d mortality, n (%) 7 (1.5) 10 (11.9) <.01* 3 (0.8) 4 (7.3) <.01*
1-y mortality, n (%) 10 (2.1) 10 (11.9) <.01* 4 (1.1) 4 (7.3) <.01*
2-y mortality, n (%) 17 (3.6) 11 (13.1) <.01* 9 (2.5) 4 (7.3) .06
5-y mortality, n (%) 25 (5.3) 21 (25) <.01* 14 (3.9) 11 (20) <.01*
8-y mortality, n (%) 38 (8.1) 22 (26.2) <.01* 24 (6.8) 12 (21.8) <.01*
Length of ICU stay, h 24 (23-28) 26 (24-46.5) <.01* 24 (22-27) 25 (23.5-27) .11
Length of hospital stay, d 5 (5-7) 6 (5-10) <.01* 5 (4.5-7) 6 (5-8) .04*
Prolonged ICU stay, n (%) 56 (11.9) 18 (21.4) .02* 24 (6.8) 5 (9.1) .57
Prolonged hospital stay, n (%) 31 (6.6) 16 (19.0) <.01* 15 (4.2) 7 (12.7) .02*
Complications, n (%)
AF 32 (6.8) 11 (13.1) .04* 15 (4.2) 6 (10.9) .04*
LCOS 93 (19.7) 24 (28.6) .08 73 (20.7) 19 (34.5) .02*
CABG, Coronary artery bypass graft; QTc, corrected QT interval; ICU, intensive care unit; AF, new-onset postoperative atrial fibrillation or flutter; LCOS, low cardiac output
syndrome. *P<.05.
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QTc is greater than 400 milliseconds, mortality is increased
and then markedly increased in patients who have QTc
greater than 500 milliseconds. Fourth, we found that
preoperative prolonged QTc adds additional information
to STS mortality risk estimates.
Our data suggest that preoperative ECG screening for the
presence of a prolonged QTc interval is a useful indicator of
the risk of short-term and long-term mortality and peri-
operative morbidity in otherwise low-risk patients
scheduled for cardiac surgery. Interventions in patients
who have prolonged QTc may depend on the cause of the
prolonged QTc, such as cessation or dose reduction of
antiarrhythmic (eg, amiodarone, procainamide, or disopyr-
amide), antipsychotic (eg, haloperidol or chlorpromazine),
antibiotic (eg, macrolides or fluoroquinolones), or antihista-
mine (eg, terfenadin) medications known to prolong
QTc.21 Perioperative normalization of electrolytes, espe-
cially potassium and magnesium, may assume greater
importance in these patients in decreasing the risks of
prolonged QTc. Barring contraindications such as reactiveTABLE 3. Comparison of outcomes of patients who had cardiac surgery a
who did not develop postoperative atrial arrhythmias
Outcome Normal QTc (n ¼ 439)
30-d mortality, n (%) 3 (0.6)
90-d mortality, n (%) 6 (1.4)
1-y mortality, n (%) 8 (1.8)
2-y mortality, n (%) 15 (3.4)
5-y mortality, n (%) 21 (4.8)
8-y mortality, n (%) 33 (7.5)
Prolonged ICU stay, n (%) 47 (10.7)
Prolonged hospital stay, n (%) 25 (5.7)
LCOS, n (%) 88 (20.0)
QTc, Corrected QT interval; RR, relative risk; CI, confidence interval; ICU, intensive care
1632 The Journal of Thoracic and Cardiovascular Surairway disease, b-blocker therapy begun at least 1 week
before surgery has been shown to be efficacious in
preventing postoperative atrial arrhythmias.22
This study has limitations. It is a single-center retro-
spective study and so subject to the possibility that QTc is
simply a surrogate marker of the true cause of mortality
and postoperative atrial arrhythmias and LCOS. The strong
association between preoperative prolonged QTc and
postoperative atrial arrhythmias in many studies supports
a causal link, at least for atrial arrhythmias. With respect
to generalizability of the study, hospital mortality in this
study is 2.9%, higher than expected in the literature.9,23
This may be due to inclusion of patients undergoing both
coronary bypass and valvular repair/replacement. This
broader inclusion may increase the applicability of the
study to general cardiac surgical units. In addition, the
results from the largest homogeneous subgroup, those
patients undergoing on-pump CABG, was similar to the
entire cohort suggesting that these results are not due to
heterogeneity of this cohort. However, the numbers of
patients who underwent valve and combined surgery arend who had a left ventricular ejection fraction greater than 40%, and
Prolonged QTc (n ¼ 73) P RR (95% CI)
5 (6.8) <.01* 2.31 (1.01-5.65)
6 (8.2) <.01* 1.73 (1.02-3.05)
6 (8.2) <.01* 1.52 (1.02-2.39)
7 (9.6) .02* 1.27 (1.01-1.69)
17 (23.3) <.01* 1.59 (1.19-2.13)
18 (24.7) <.01* 1.36 (1.11-1.67)
14 (19.2) .04* 1.13 (1.01-1.30)
11 (15.1) <.01* 1.25 (1.02-1.56)
18 (24.7) .37 1.04 (0.948-1.14)
unit; LCOS, low cardiac output syndrome. *P<.05.
gery c May 2014
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have allowed analysis of other subgroups. The incidence
of postoperative atrial arrhythmias was lower than in other
studies.24,25 We determined the postoperative atrial
arrhythmias from 12-lead ECGs in the hospital system,
which would have underestimated the true incidence. Our
study used the Bazett formula to correct the QTc interval,
which seems to overestimate the QTc interval at a faster
heart rate than Hodges’ linear correction formula.
However, the Bazett formula is still the most commonly
used in clinical practice and research.
CONCLUSIONS
Prolongation of the QTc interval in a preoperative ECG
of patients undergoing cardiac surgery and who have an
LVEF greater than 40% is a significant risk factor for
short-term and long-term mortality, prolonged ICU and
hospital stays, postoperative atrial arrhythmias, and
LCOS. If the QTc exceeds 500 milliseconds, 25% of
patients will develop postoperative atrial arrhythmias and
25% will not survive to hospital discharge. We recommend
routine preoperative ECG screening in all patients and then
optimization of potential contributors when prolonged QTc
is observed.
The authors thanks the cardiothoracic surgeon team at St. Paul’s
Hospital, University of British Columbia, Vancouver, Canada for
their contribution.
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